CLINICAL_TRIALS
research
· 2015-07-14
Clinical Trial Update: Four Versus Six Cycles of Pemetrexed/Platinum for MPM [Phase 2]
Summary
An update on a Phase 2 trial comparing four versus six cycles of pemetrexed/platinum therapy for malignant pleural mesothelioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ain Shams University | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: UNKNOWN